Target intelligence / Profile preview

Kinesin family member C3 (KIFC3)

Target
KIFC3
Molecular classification
Motor protein, Kinesin superfamily protein, Microtubule-associated protein, Other
01

Overview

Kinesin family member C3 (KIFC3) is a minus end–directed microtubule motor protein belonging to the kinesin superfamily. It is involved in intracellular cargo transport, particularly in the integration and apical transport of vesicles in epithelial cells. KIFC3 has been shown to promote cell proliferation, migration, invasion, and the epithelial-to-mesenchymal transition in cancer, especially in colorectal and hepatocellular carcinomas. High levels of KIFC3 are associated with increased malignancy, poor prognosis, and resistance to chemotherapy (notably docetaxel). Mechanistically, KIFC3 acts at least in part by activating the PI3K/AKT/mTOR pathway, and it also plays a physiological role in epithelial vesicle trafficking and cell polarity[1][2][4].

Other names
Kinesin-like protein KIFC3KIFC3
02

Mechanism of action

Potential for inhibition: reduction of PI3K/AKT/mTOR signaling, leading to reduced proliferation, migration, invasion, and EMT in cancer cells[1]. Overexpression confers resistance to docetaxel, likely through cytoskeletal and trafficking changes[1].

03

Biological functions

Intracellular cargo transportMinus end–directed microtubule motor activityGolgi localization and integrationApical transport in epithelial cellsPositive regulation of cell migrationPositive regulation of cell proliferationRegulation of epithelial-to-mesenchymal transition (EMT)Cell adhesionCell invasion
04

Disease associations

CancerChemoresistance (notably in breast cancer)Colorectal cancer proliferation, migration, invasionHepatocellular carcinoma metastasis
05

Safety considerations

Essential role in intracellular transport and epithelial cell polarity suggests potential off-target effects and toxicity in normal tissue[4].No clinical inhibitors currently, so therapeutic window is not established.
06

Interacting drugs

No direct, approved, small-molecule drugs, but docetaxel resistance is associated with KIFC3[1][2].

2 more in the full profile.

07

Biomarkers

Elevated KIFC3 expression is a potential biomarker for poor prognosis in colorectal and hepatocellular carcinoma[1][2].

Beyond the preview

Go deeper on Kinesin family member C3 (KIFC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin family member C3 (KIFC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call